Ambow Education Holding Ltd. Shareholder GL Asia Mauritius II Cayman Ltd. Responds to Dr. Jin Huang's Letter

  Ambow Education Holding Ltd. Shareholder GL Asia Mauritius II Cayman Ltd.
                      Responds to Dr. Jin Huang's Letter

PR Newswire

BEIJING, June 26, 2013

BEIJING, June 26, 2013 /PRNewswire/ --GL Asia Mauritius II Cayman Limited
("GLAM"), a major shareholder of Ambow Education Holding Ltd. ("Ambow"), today
issued the following response to a recent open letter from Ambow Chairwoman
and CEO Dr. Jin Huang:

We wish to address Dr. Jin Huang's June 24, 2013 open letter to Ambow
shareholders concerning the Grand Court of the Cayman Islands June 7, 2013
Order appointing provisional liquidators for Ambow Education Holding Ltd. Dr.
Huang's letter is materially inaccurate and appears calculated to interfere
with the Provisional Liquidators' Court-ordered mandate to conduct a
transparently independent investigation into alleged wrongful conduct by
senior management and restore shareholder confidence and value. The Court
appointed those provisional liquidators only after a full and fair hearing in
which the petitioner (GL Asia Mauritius II Cayman Limited ("GLAM")), Ambow,
and Dr. Huang herself all had the opportunity to present evidence and be

GLAM has been an Ambow shareholder since 2005 and invested approximately $70
million in Ambow. GLAM sought the provisional liquidators' appointment
because we concluded that this was the only way for Ambow's shareholders to
restore profitability and shareholder value. As Ambow's public Securities and
Exchange Commission ("SEC") filings demonstrate, Ambow senior management's
pre-Petition conduct has depressed the Company's financial performance and
diminished shareholder value:

  oImmediately upon learning that a whistleblower had accused Ambow senior
    management of fraudulent conduct, Ambow's Audit Committee initiated an
    investigation into alleged wrongdoing by Dr. Huang and other senior
    management members on July 3, 2012. By March 2013, the Audit Committee's
    counsel at Fenwick & West LLP ("Fenwick") had concluded that the Audit
    Committee investigation could not conclude so long as Dr. Huang remained
    Ambow's CEO and President. But when the Audit Committee asked that Dr.
    Huang resign or take a leave of absence, she refused, setting off a chain
    of resignations by the Company's three independent directors, including
    two Audit Committee members, and Fenwick.
  oPricewaterhouseCoopers Zhong Tian CPAs Limited Company ("PWC")—the "Big
    Four accounting firm" Dr. Huang touts in her letter— resigned as the
    Company's outside independent auditors because "of its concerns that the
    [Audit Committee] Investigation may not be given the necessary resources
    and time, and the presence of existing management may make conducting an
    investigation of the scope that PWC believes is warranted unlikely."
  oBecause of these resignations and other negative events surrounding Ambow,
    the NYSE suspended trading of Ambow's ADSs.
  oIn the year before that trading suspension, with Dr. Huang at the helm,
    the trading price of Ambow's ADSs plummeted approximately 87%.
  oFor the second year in a row, Ambow has failed to timely file its Annual
    Report on SEC Form 20-F, and it appears unlikely to that Ambow will be
    able to disclose audited financial statements for 2012 any time soon.

In appointing the provisional liquidators, the Court considered not only this
and other publicly available information, but additional information that
included affidavit testimony from Dr. Huang and others concerning events at
Ambow from July 2012 through the present. If Dr. Huang truly believes that
shareholders "are entitled to transparency[,] good governance," and "accurate,
current information," then she should make this information—which out of
deference to Ambow was filed confidentially with the Court—available to Ambow
investors, as well, so that they can make an informed decision concerning the
Company's future direction. We believe that if such information were made
available to shareholders, it would not only confirm the events described in
this letter, but also contradict many of the other assertions in Dr. Huang's
June 24, 2013 letter.

It also appears that Dr. Huang is trying to distract from the real issues by
suggesting that our interests differ from those of other shareholders because,
Dr. Huang contends, we intend to take Ambow private. We have no such plans at
this time, and our only interest is in seeing the Company complete the Audit
Committee investigation and return to thriving as a publicly traded company.
We believe that these goals would similarly benefit all Ambow's
constituencies—shareholders, creditors, employees, customers and suppliers
(among others).

We are confident that the provisional liquidators will resist any attempt by
Dr. Huang to interfere with their conducting a transparently independent
investigation or running Ambow in the best interests of all shareholders. We
believe that all shareholders expect the provisional liquidators to fully and
independently fulfill the Court's mandate.

We urge all Ambow shareholders to demand all pertinent information and, after
informing themselves fully, to make sure their voices are heard by writing to
the Company and the Company's provisional liquidators, or taking any action
they deem appropriate, to demand that a transparently independent
investigation into the allegations of senior management significant misconduct
be completed and all steps necessary to restore shareholder confidence and
value be taken promptly. To that end, we believe that Dr. Huang's immediate
resignation is necessary to achieve these goals, will prevent her from leading
the Company further astray, and is in Ambow's best interests moving forward.

Contact for GL Asia Mauritius II Cayman Ltd.:

  Todd Fogarty
  Kekst and Company

SOURCE GL Asia Mauritius II Cayman Ltd.
Press spacebar to pause and continue. Press esc to stop.